(Q48939674)

17 February 2018

title

Prolonged survival when temozolomide is added to accelerated radiotherapy for glioblastoma multiforme. (English)

1 reference

17 February 2018

Adaptive radiation therapy

main subject

0 references

0 references

1 reference

Matthias Guckenberger

1

1 reference

17 February 2018

Giles H Vince

object named as

Giles H Vince

4

0 references

Mathias Buttmann

object named as

Mathias Buttmann

3

0 references

Michael Flentje

6

object named as

Michael Flentje

1 reference

17 February 2018

author name string

Mario Mayer

2

1 reference

17 February 2018

Reinhart A Sweeney

5

1 reference

17 February 2018

publication date

18 August 2011

1 reference

17 February 2018

Strahlentherapie und Onkologie

published in

1 reference

17 February 2018

volume

187

1 reference

17 February 2018

issue

9

1 reference

17 February 2018

page(s)

548-554

1 reference

17 February 2018

https://scigraph.springernature.com/pub.10.1007/s00066-011-2242-6

exact match

0 references

cites work

A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-2242-6

Modifying radical radiotherapy in high grade gliomas; shortening the treatment time through acceleration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-2242-6

Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-2242-6

Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-2242-6

Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-2242-6

The effect of waiting for radiotherapy for grade III/IV gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-2242-6

Perioperative high-dose-rate brachytherapy in the treatment of recurrent malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-2242-6

Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-2242-6

Accelerated hyperfractionated radiotherapy in supratentorial malignant astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-2242-6

Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-2242-6

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-2242-6

The importance of tumor volume in the prognosis of patients with glioblastoma: comparison of computerized volumetry and geometric models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-2242-6

Delay in radiotherapy shortens survival in patients with high grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-2242-6

The timing of cranial radiation in elderly patients with newly diagnosed glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-2242-6

[Prediction of clinical course of glioblastomas by MRI during radiotherapy].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-2242-6

Accelerated hyperfractionated radiotherapy in 149 patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-2242-6

Bevacizumab as a treatment option for radiation-induced cerebral necrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-2242-6

Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-2242-6

Hyperfractionated and accelerated-hyperfractionated radiotherapy for glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-2242-6

A randomized trial comparing 35Gy in ten fractions with 60Gy in 30 fractions of cerebral irradiation for glioblastoma multiforme and older patients with anaplastic astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-2242-6

Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-2242-6

Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-2242-6

Comparison of accelerated hyperfractionated radiotherapy and conventional radiotherapy for supratentorial malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-2242-6

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-2242-6

Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-2242-6

Treatment of recurrent malignant gliomas with stereotactic intensity modulated radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-2242-6

Radiographic and histopathologic observations after combined EGFR inhibition and hypofractionated stereotactic radiosurgery in patients with recurrent malignant gliomas

21 January 2018

1 reference

12 December 2020

Population-based study of pseudoprogression after chemoradiotherapy in GBM.

1 reference

12 December 2020

Pseudoprogression following chemoradiotherapy for glioblastoma multiforme.

1 reference

12 December 2020

An analysis of dose-effect relationship in the radiotherapy of malignant gliomas

1 reference

12 December 2020

10.1007/S00066-011-2242-6

Identifiers

DOI

1 reference

17 February 2018

1 reference

17 February 2018